Global Citizen Capital and two of its portfolio companies: Forall Biotech and MitoBioMed have officially joined #China and its national #coronavirus initiative.
First work stream: utilize molecular medicine research to prevent the virus from replication
Second work stream: mobilize proven cellular rejuvenation technology to boost immunity of infected patients
All hands on deck!#武汉加油
https://worldhealth.net/news/global-research-pushes-molecular-medicine-therapy-coronavirus-treatment/
Comments